home / stock / gmab / gmab articles

GMAB Articles, Genmab A/S

Stock Information
Company Name: Genmab A/S
Stock Symbol: GMAB
Market: NYSE
Website: genmab.com
Menu
GMAB GMAB Quote GMAB Short GMAB News GMAB Articles GMAB Message Board
Get GMAB Alerts

News, Short Squeeze, Breakout and More Instantly...
AbbVie/Genmab's Epkinly FDA Approval Is A Positive Step, Analyst Says Additional Expansion Opportunities Underway | Benzinga

On Wednesday, the FDA approved Epkinly (epcoritamab-bysp) as the first and only T-cell-engaging bispecific antibody administered subcutaneousl...
Intuit, Workday And Other Big Stocks Moving Lower In Friday's Pre-Market Session | Benzinga

U.S. stock futures were higher this morning, with the Dow futures gaining around 50 points on Friday. Shares of Intuit Inc. (NASDAQ:INTU) fell shar...

What's Going On With Danish Healthcare Firm Genmab Stock? | Benzinga

Monday, in a significant legal update for Genmab A/S (NASDAQ:GMAB), an appeal arbitrator has dismissed the biotech company’s b...

Oracle Reports Weak Sales, Joins Kinetik, Lucid Group And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session | Benzinga

U.S. stock futures were higher this morning, with the Dow Jones futures gaining over 50 points on Tuesday. Shares of Oracle Corporation (NYSE: ORC...
United Airlines, Interactive Brokers And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session | Benzinga

U.S. stock futures traded lower this morning on Wednesday. Here are some big stocks recording losses in today’s pre-market trading session. ...

AstraZeneca's Tagrisso-Chemo Combo Data In Lung Cancer Sets High Bar For Johnson & Johnson's Cancer Drug: Analyst | Benzinga

On Sunday night, AstraZeneca Plc (NASDAQ: AZN) presented the Phase 3 FLAURA2 results evaluating Tagrisso plus chemotherapy versus Tagriss...

Encouraging Data From Seagen/Genmab's Cervical Cancer Study - Tivdak Success Sets Stage For New Indications | Benzinga

Seagen Inc (NASDAQ: SGEN) and Genmab A/S (NASDAQ: GMAB) released topline data from the Phase 3 innovaTV 301 global trial in recurren...
Next 10